U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07711483) titled 'GLORY: Glofit-GemOx With Liso-Cel For Lymphoma' on July 14.
Brief Summary: The goal of this clinical trial is to assess the clinical efficacy of bridging therapy with glofitamab/gemcitabine/oxaliplatin (Glofit-GemOx) followed by lisocabtagene maraleucel (liso-cel) in relapsed/refractory large B-cell lymphomas. This clinical trial also aims to investigate other efficacy parameters of the combination of Glofit-GemOx plus liso-cel and assess the safety of the combination of Glofit-GemOx bridging plus liso-cel. The main questions it aims to answer are:
* How effective Glofit-GemOx bridged to liso-cel therapy is compared to liso-cel alo...